Improved targeting of photosensitizers by intratumoral administration of immunoconjugates

Seema Gupta, A. K. Mishra, K. Muralidhar, Viney Jain

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Biodistribution of technetium (99mTc) labeled hematoporphyrin derivative (HpD, Photosan-3) conjugated to a monoclonal antibody to carcinoembryonic antigen (anti-CEA) was compared following intravenous (i.v.) and intratumoral (i.t.) administration in solid Ehrlich ascites tumor bearing mice. Images of mice at different time intervals were acquired after injection of radiolabeled PS-3 in either conjugated or unconjugated forms. Quantitative estimation of the radiolabel in different tissues was performed by selecting the different region of interests (ROIs). Maximum accumulation of both free and antibody conjugated PS-3 following i.v. administration was observed in liver followed by tumor. Tumor/muscle (T/N) ratio was more with free PS-3 compared to conjugated PS-3. Pharmacokinetics of free and conjugated PS-3 was also different with faster accumulation of conjugated PS-3 in the tumor. With intratumoral administration of anti-CEA-PS-3-99mTc, specific accumulation and retention of the sensitizer was observed in the tumor tissue. Since, direct injection of antibody conjugated photosensitizer into the tumor resulted in longer retention of the dye in the tumor with no accumulation in the normal tissues, the present results imply that the toxicity to normal tissues could be reduced significantly with selective destruction of the tumor following photodynamic treatment with the use of i.t. administration of specific antibodies conjugated to photosensitizers.

Original languageEnglish (US)
Pages (from-to)295-301
Number of pages7
JournalTechnology in Cancer Research and Treatment
Volume3
Issue number3
StatePublished - Jun 2004
Externally publishedYes

Fingerprint

Immunoconjugates
Photosensitizing Agents
Neoplasms
Antibodies
Carcinoembryonic Antigen
Intravenous Administration
Hematoporphyrin Derivative
Ehrlich Tumor Carcinoma
Injections
Technetium
Coloring Agents
Pharmacokinetics
Monoclonal Antibodies
Muscles
Liver

Keywords

  • Biodistribution
  • CEA
  • Ehrlich ascites tumor
  • Immunoconjugates
  • Intratumoral administration
  • Monoclonal antibody
  • Photosan-3
  • Photosensitization

ASJC Scopus subject areas

  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

Improved targeting of photosensitizers by intratumoral administration of immunoconjugates. / Gupta, Seema; Mishra, A. K.; Muralidhar, K.; Jain, Viney.

In: Technology in Cancer Research and Treatment, Vol. 3, No. 3, 06.2004, p. 295-301.

Research output: Contribution to journalArticle

Gupta, Seema ; Mishra, A. K. ; Muralidhar, K. ; Jain, Viney. / Improved targeting of photosensitizers by intratumoral administration of immunoconjugates. In: Technology in Cancer Research and Treatment. 2004 ; Vol. 3, No. 3. pp. 295-301.
@article{e4de1128b5df43c99143ec4ddd7e872d,
title = "Improved targeting of photosensitizers by intratumoral administration of immunoconjugates",
abstract = "Biodistribution of technetium (99mTc) labeled hematoporphyrin derivative (HpD, Photosan-3) conjugated to a monoclonal antibody to carcinoembryonic antigen (anti-CEA) was compared following intravenous (i.v.) and intratumoral (i.t.) administration in solid Ehrlich ascites tumor bearing mice. Images of mice at different time intervals were acquired after injection of radiolabeled PS-3 in either conjugated or unconjugated forms. Quantitative estimation of the radiolabel in different tissues was performed by selecting the different region of interests (ROIs). Maximum accumulation of both free and antibody conjugated PS-3 following i.v. administration was observed in liver followed by tumor. Tumor/muscle (T/N) ratio was more with free PS-3 compared to conjugated PS-3. Pharmacokinetics of free and conjugated PS-3 was also different with faster accumulation of conjugated PS-3 in the tumor. With intratumoral administration of anti-CEA-PS-3-99mTc, specific accumulation and retention of the sensitizer was observed in the tumor tissue. Since, direct injection of antibody conjugated photosensitizer into the tumor resulted in longer retention of the dye in the tumor with no accumulation in the normal tissues, the present results imply that the toxicity to normal tissues could be reduced significantly with selective destruction of the tumor following photodynamic treatment with the use of i.t. administration of specific antibodies conjugated to photosensitizers.",
keywords = "Biodistribution, CEA, Ehrlich ascites tumor, Immunoconjugates, Intratumoral administration, Monoclonal antibody, Photosan-3, Photosensitization",
author = "Seema Gupta and Mishra, {A. K.} and K. Muralidhar and Viney Jain",
year = "2004",
month = "6",
language = "English (US)",
volume = "3",
pages = "295--301",
journal = "Technology in Cancer Research and Treatment",
issn = "1533-0346",
publisher = "Adenine Press",
number = "3",

}

TY - JOUR

T1 - Improved targeting of photosensitizers by intratumoral administration of immunoconjugates

AU - Gupta, Seema

AU - Mishra, A. K.

AU - Muralidhar, K.

AU - Jain, Viney

PY - 2004/6

Y1 - 2004/6

N2 - Biodistribution of technetium (99mTc) labeled hematoporphyrin derivative (HpD, Photosan-3) conjugated to a monoclonal antibody to carcinoembryonic antigen (anti-CEA) was compared following intravenous (i.v.) and intratumoral (i.t.) administration in solid Ehrlich ascites tumor bearing mice. Images of mice at different time intervals were acquired after injection of radiolabeled PS-3 in either conjugated or unconjugated forms. Quantitative estimation of the radiolabel in different tissues was performed by selecting the different region of interests (ROIs). Maximum accumulation of both free and antibody conjugated PS-3 following i.v. administration was observed in liver followed by tumor. Tumor/muscle (T/N) ratio was more with free PS-3 compared to conjugated PS-3. Pharmacokinetics of free and conjugated PS-3 was also different with faster accumulation of conjugated PS-3 in the tumor. With intratumoral administration of anti-CEA-PS-3-99mTc, specific accumulation and retention of the sensitizer was observed in the tumor tissue. Since, direct injection of antibody conjugated photosensitizer into the tumor resulted in longer retention of the dye in the tumor with no accumulation in the normal tissues, the present results imply that the toxicity to normal tissues could be reduced significantly with selective destruction of the tumor following photodynamic treatment with the use of i.t. administration of specific antibodies conjugated to photosensitizers.

AB - Biodistribution of technetium (99mTc) labeled hematoporphyrin derivative (HpD, Photosan-3) conjugated to a monoclonal antibody to carcinoembryonic antigen (anti-CEA) was compared following intravenous (i.v.) and intratumoral (i.t.) administration in solid Ehrlich ascites tumor bearing mice. Images of mice at different time intervals were acquired after injection of radiolabeled PS-3 in either conjugated or unconjugated forms. Quantitative estimation of the radiolabel in different tissues was performed by selecting the different region of interests (ROIs). Maximum accumulation of both free and antibody conjugated PS-3 following i.v. administration was observed in liver followed by tumor. Tumor/muscle (T/N) ratio was more with free PS-3 compared to conjugated PS-3. Pharmacokinetics of free and conjugated PS-3 was also different with faster accumulation of conjugated PS-3 in the tumor. With intratumoral administration of anti-CEA-PS-3-99mTc, specific accumulation and retention of the sensitizer was observed in the tumor tissue. Since, direct injection of antibody conjugated photosensitizer into the tumor resulted in longer retention of the dye in the tumor with no accumulation in the normal tissues, the present results imply that the toxicity to normal tissues could be reduced significantly with selective destruction of the tumor following photodynamic treatment with the use of i.t. administration of specific antibodies conjugated to photosensitizers.

KW - Biodistribution

KW - CEA

KW - Ehrlich ascites tumor

KW - Immunoconjugates

KW - Intratumoral administration

KW - Monoclonal antibody

KW - Photosan-3

KW - Photosensitization

UR - http://www.scopus.com/inward/record.url?scp=2942648707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942648707&partnerID=8YFLogxK

M3 - Article

C2 - 15161322

AN - SCOPUS:2942648707

VL - 3

SP - 295

EP - 301

JO - Technology in Cancer Research and Treatment

JF - Technology in Cancer Research and Treatment

SN - 1533-0346

IS - 3

ER -